Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home

American Journal Of Biomedical Science & Pharmaceutical Innovation

Peer Reviewed | Open Access | E-ISSN: 2771-2753
Published Article

Antidiabetic and Testoprotective Potential of Vernonia Amygdalina In Wistar Rats

Antidiabetic and Testoprotective Potential of Vernonia Amygdalina In Wistar Rats

  • Dr. Ayesha Rahman
    Department of Biomedical Sciences, Faculty of Health Sciences, National Institute of Medical Research, Islamabad, Pakistan
Vernonia amygdalina diabetes mellitus testicular protection

Diabetes mellitus is a complex metabolic disorder associated with persistent hyperglycemia, oxidative stress, and progressive impairment of multiple physiological systems, including male reproductive function. Diabetic-induced testicular dysfunction has emerged as a significant complication characterized by disrupted hormonal regulation, impaired spermatogenesis, oxidative damage, and reduced reproductive capacity. Natural medicinal resources with antioxidant and glucose-regulating properties have gained considerable attention as potential therapeutic alternatives for mitigating diabetes-associated complications. Vernonia amygdalina, a widely utilized medicinal plant in African traditional medicine, contains bioactive phytoconstituents with reported antidiabetic, antioxidant, and protective biological activities. This research examines the antidiabetic and testoprotective potential of Vernonia amygdalina in alloxan-induced diabetic male Wistar rats through an integrated evaluation of metabolic regulation, oxidative stress modulation, and reproductive tissue preservation. The study framework is based on the hypothesis that ethanolic extract of Vernonia amygdalina may reduce hyperglycemia-induced cellular injury by enhancing antioxidant defense mechanisms and maintaining testicular structural and functional integrity. Previous investigations demonstrate that diabetes negatively affects male reproductive physiology through alterations in insulin signaling, gonadotropin regulation, and oxidative imbalance (Ballester et al., 2004; Jangir & Jain, 2014). Evidence regarding Vernonia amygdalina indicates significant therapeutic activity against diabetic complications, particularly through regulation of oxidative biomarkers and improvement of endogenous antioxidant systems (Asante & Wiafe, 2023; Edo et al., 2024). The findings from the proposed analytical framework highlight the potential of Vernonia amygdalina as a multifunctional botanical intervention for diabetes-associated reproductive complications. This research contributes to the growing scientific understanding of plant-based approaches in managing metabolic disorders and provides a foundation for further pharmacological investigations.

Abo, K. A., Fred-Jaiyesimi, A. A., & Jaiyesimi, A. E. A. M. (2008). Ethnobotanical studies of medicinal plants used in the management of diabetes mellitus in South Western Nigeria. Journal of Ethnopharmacology, 111(1), 67–71.

Amira, O. C., & Okubadejo, O. U. (2007). Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. BMC Complementary and Alternative Medicine, 7,30.

Asafo-Agyei, T., Appau, Y., Barimah, K. B., & Asase, A. (2023). Medicinal plants used for management of diabetes and hypertension in Ghana. Heliyon, 9(12), e22977.

Asante, D. B., & Wiafe, G. A. (2023). Therapeutic benefit of Vernonia amygdalinain the treatment of diabetes and its associated complications in preclinical studies. Journal of Diabetes Research, 2023,3159352.

Ballester, J., Muñoz, M. C., Domínguez, J., Rigau, T., Guinovart, J. J., & Rodríguez-Gil, J. E. (2004). Insulin-dependent diabetes affects testicular function by FSH-and LH-linked mechanisms. Journal of Andrology, 25(5), 706–719.

Barrachina, F., Battistone, M. A., Castillo, J., Mallofré, C., Jodar, M., Breton, S., & Oliva, R. (2022). Sperm acquire epididymis-derived proteins through epididymosomes. Human Reproduction, 37(4), 651–668.

Burkill,H. M. (1994). The useful plants of West Tropical Africa(Vol. 2: Families E–I, 2nd ed., pp. xii–636). Royal Botanic Gardens, Kew.

Edo, G. I., Jikah, A. N., Onoharigho, F. O., Akpoghelie, P. O., Agbo, J. J., Ekokotu, H. A., Ugbune, U., Ezekiel, G. O., Emakpor, O. L., Oghroro, E. E. A., Ojulari, A. E., Okoronkwo, K. A., Omoruwou, P. E., & Owheruo, J. O. (2024). The ameliorative effects of Vernonia amygdalinaextract on superoxide dismutase and glutathione s-transferase on alloxan-induced diabetes in male Wistar rats. Food Chemistry Advances, 4,100620.

Erasto, P., Grierson, D. S., & Afolayan, A. J. (2006). Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. Journal of Ethnopharmacology, 106,117–129.

Ezuruike, F. U., & Prieto, J. M. (2014). The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations. Journal of Ethnopharmacology, 155(2), 857–924.

Frimpong, E. K., Thembane, N., Hlatshwayo, S., Ngcobo, M., & Gqaleni, N. (2024). Indigenous medicinal plants used in the management of diabetes in Africa: 5 years (2019–2024) in perspective. Plants, 13(14), 1898.

Hamowia, A. M., & Saffaf, A. M. (1994). Pharmacological studies on Vernonia amygdalina(Del) and Tithonia diversifolia (Gray). Veterinary Medicine Giza, 2,91–97.

Howard, C. B., Johnson, W. K., Pervin, S.,& Izevbigie, E. B. (2015). Recent perspectives on the anticancer properties of aqueous extracts of Nigerian Vernonia amygdalina. Botanics: Targets and Therapy, 5,65–76.

Huffman, M. A. (2003). Animal self-medication and ethno-medicine: Exploration and exploitation of the medicinal properties of plants. Proceedings of the Nutrition Society, 62(2), 371–381.

Igile, G. (1996). Vernoniosides D and E, two novel saponins from Vernonia amygdalina. ChemInform, 27(10).

Integrated Health Services (IHS). (2013). WHO traditional medicine strategy: 2014–2023. World Health Organization.

Islam, K., Islam, R., Nguyen, I., Malik, H., Pirzadah, H., Shrestha, B., Lentz, I. B., Shekoohi, S., & Kaye, A. D. (2025). Diabetes mellitus and associated vascular disease: Pathogenesis, complications, and evolving treatments. Advances in Therapy, 42(6), 2659–2678.

Jangir, R. N., & Jain, G. C. (2014). Diabetes mellitus-induced impairment of male reproductive functions: A review. Current Diabetes Reviews, 10(3), 147–157.

O'Donnell, L., Stanton, P., & de Kretser, D. M. (2017). Endocrinology of the male reproductive system and spermatogenesis. In Feingold, K. R., Ahmed, S. F., Anawalt, B., et al. (Eds.), Endotext. MDText.com, Inc.

Poli, M. A., Hossain, M. J., Kholil, I., Yasmin, S., Bhowmick, B., & Kundu, L. R. (2025). Traditional medicine use and associated factors in chronic patients in Jamalpur, Bangladesh: A cross-sectional study. Frontiers in Public Health, 13,1548728.

Regassa, A. (2000). The use of herbal preparations for tick control in Western Ethiopia. Journal of the South African Veterinary Association, 71(4), 240–243.

Rizvi, S. A. A., Einstein, G. P., Tulp, O. L., Sainvil, F., & Branly, R. (2022). Introduction to traditional medicine and their role in prevention and treatment of emerging and re-emerging diseases. Biomolecules, 12(10), 1442.

Ssenyange, C. W., Namulindwa, A., Oyik, B., & Ssebuliba, J. (2015). Plants used to manage type II diabetes mellitus in selected districts of central Uganda. African Health Sciences, 15(2), 496–502.

Zhang, W., Tong, L., Jin, B., & Sun, D. (2025). Diabetic testicular dysfunction and spermatogenesis impairment: Mechanisms and therapeutic prospects. Frontiers in Endocrinology, 16,1653975.